Overall, AML cells alter the function of BM-MSCs through Gal-3 upregulation in BM-MSCs, and Gal-3 upregulation in the BMME provides survival signals to AML cells, thereby creating a self-reinforcing niche conducive to escape from chemotherapy and the immune response. This evidence concerns the gene LGALS3 and acute myeloid leukemia.